ES2064487T3 - Nuevos inhibidores de glicosidasa. - Google Patents

Nuevos inhibidores de glicosidasa.

Info

Publication number
ES2064487T3
ES2064487T3 ES89870215T ES89870215T ES2064487T3 ES 2064487 T3 ES2064487 T3 ES 2064487T3 ES 89870215 T ES89870215 T ES 89870215T ES 89870215 T ES89870215 T ES 89870215T ES 2064487 T3 ES2064487 T3 ES 2064487T3
Authority
ES
Spain
Prior art keywords
new
glycosidase inhibitors
glycosidase
inhibitors
dideoxi
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89870215T
Other languages
English (en)
Inventor
George William John Fleet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Monsanto Co
Original Assignee
Monsanto Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Monsanto Co filed Critical Monsanto Co
Application granted granted Critical
Publication of ES2064487T3 publication Critical patent/ES2064487T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12—Oxygen or sulfur atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

LA ESPECIFIDAD DE LA ACTIVIDAD INHIBIDORA GLICOSIDASA DEL NUEVO ALLITOL-L-IMINO-1,4-DIDEOXI-1,4 (I) ES SUSTANCIALMENTE CAMBIADO POR SUSTITUIR EL NITROGENO DEL ANILLO CON UN ALQUIL O BENCIL SUSTITUYENTE.
ES89870215T 1988-12-22 1989-12-21 Nuevos inhibidores de glicosidasa. Expired - Lifetime ES2064487T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/288,735 US4894388A (en) 1988-12-22 1988-12-22 Glycosidase inhibitors and use thereof

Publications (1)

Publication Number Publication Date
ES2064487T3 true ES2064487T3 (es) 1995-02-01

Family

ID=23108416

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89870215T Expired - Lifetime ES2064487T3 (es) 1988-12-22 1989-12-21 Nuevos inhibidores de glicosidasa.

Country Status (7)

Country Link
US (1) US4894388A (es)
EP (1) EP0375651B1 (es)
JP (1) JP2948847B2 (es)
AT (1) ATE112558T1 (es)
CA (1) CA2006269C (es)
DE (1) DE68918681T2 (es)
ES (1) ES2064487T3 (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5043416A (en) * 1988-09-26 1991-08-27 Monsanto Company Method of inhibiting virus
US5013842A (en) * 1990-01-22 1991-05-07 Monsanto Company Synthesis of chiral pyrrolidine and piperidine glycosidase inhibitors
US5863903A (en) * 1994-03-09 1999-01-26 Novo Nordisk A/S Use of hydroxy alkyl piperidine and pyrrolidine compounds to treat diabetes
EP0749423B1 (en) * 1994-03-09 2003-06-18 Novo Nordisk A/S Piperidines and pyrrolidines
US5650413A (en) * 1995-06-07 1997-07-22 Glycodesign Inc. Derivatives of swainsonine, processes for their preparation and their use as therapeutic agents
IL124109A (en) 1995-09-08 2001-10-31 Novo Nordisk As Pharmaceutical composition of 2-alkylpyrrolidines for use in the manufacture of medicaments for the treatment of diabetes
EP0934318A1 (en) * 1996-10-01 1999-08-11 Glycodesign Inc. Novel 3, 5, and/or 6 substituted analogues of swainsonine, processes for their preparation and their use as therapeutic agents
US6395745B1 (en) 1997-04-15 2002-05-28 Glycodesign, Inc. Alkaloid halide salts of swainsonine and methods of use
CA2307595A1 (en) * 1997-10-24 1999-05-06 Glycodesign Inc. Synthesis of swainsonine salts
US7256005B2 (en) 1999-08-10 2007-08-14 The Chancellor, Masters And Scholars Of The University Of Oxford Methods for identifying iminosugar derivatives that inhibit HCV p7 ion channel activity
HK1046869A1 (zh) 1999-08-10 2003-01-30 The Chancellor, Masters And Scholars Of The University Of Oxford 使用长链n烷基化合物及其恶衍生物作为抗病毒成分
AU2006272497B2 (en) 2005-07-27 2012-07-19 University Of Florida Research Foundation, Inc. Small compounds that correct protein misfolding and uses thereof
KR20090040906A (ko) * 2006-08-02 2009-04-27 유나이티드 세러퓨틱스 코오포레이션 바이러스 감염의 리포솜 치료
CA2666814A1 (en) * 2006-08-21 2008-05-29 United Therapeutics Corporation Combination therapy for treatment of viral infections
WO2009118658A2 (en) * 2008-03-26 2009-10-01 University Of Oxford Endoplasmic reticulum targeting liposomes
EP2410989A2 (en) * 2009-03-27 2012-02-01 The Chancellor, Masters and Scholars of the University of Oxford Cholesterol level lowering liposomes
IN2012DN00352A (es) 2009-06-16 2015-08-21 Bikam Pharmaceuticals Inc
CN106431988A (zh) 2011-06-14 2017-02-22 比卡姆药品公司 视蛋白结合配体、组合物及使用方法
CA2856703A1 (en) 2011-10-19 2013-04-25 Bikam Pharmaceuticals, Inc. Opsin-binding ligands, compositions and methods of use
JP6126118B2 (ja) 2011-11-30 2017-05-10 ビカム ファーマスーティカルス，インコーポレイテッド オプシン結合性リガンド、組成物、及び使用方法
EP2785178B1 (en) 2011-12-01 2019-05-01 Bikam Pharmaceuticals, Inc. Opsin-binding ligands, compositions and methods of use
WO2016160524A1 (en) * 2015-03-27 2016-10-06 Cornell University Efficient synthesis of nicotinamide mononucleotide

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3312716A (en) * 1964-08-11 1967-04-04 Aldrich Chem Co Inc 4-hydroxy-3-pyrrolidinemethanols
US4999360A (en) * 1987-12-21 1991-03-12 Monsanto Company Method of inhibiting virus

Also Published As

Publication number Publication date
EP0375651A1 (en) 1990-06-27
JP2948847B2 (ja) 1999-09-13
EP0375651B1 (en) 1994-10-05
CA2006269C (en) 1998-09-15
ATE112558T1 (de) 1994-10-15
CA2006269A1 (en) 1990-06-22
US4894388A (en) 1990-01-16
DE68918681D1 (de) 1994-11-10
DE68918681T2 (de) 1995-03-30
JPH02212470A (ja) 1990-08-23

Similar Documents

Publication Publication Date Title
ES2064487T3 (es) Nuevos inhibidores de glicosidasa.
NO20073265L (no) Agonistananalog av amylin
ES2174989T3 (es) Pirido(3,2-e)pirazinonas con antiasmatica y procedimiento para su preparacion.
MX9102407A (es) 4 arilpiperazinas y 4-arilpiperidinas novedosas.
ES2106965T3 (es) Nuevas 4-aza-5alfa-androstan-3-onas 7beta-sustituidas como inhibidores de 5alfa-reductasa.
ES2125372T3 (es) Derivados de piperazina utiles como inhibidores de la calmodulina.
NL971014I2 (nl) Heterocyclische verbindingen.
ES2087107T3 (es) Sulfonilaminocarboniltriazolinonas.
ES2159798T3 (es) Derivados heterociclicos como inhibidores de la agregacion plaquetaria.
ES2109949T3 (es) Alteracion enzimatica del crecimiento del pelo.
SG49228A1 (en) Use of 2-amino-6-A-propyl-amino-4,5,6,7- tetrahydrobenzothiazole(pramipexol) as a antidepressant activity
ES2148329T3 (es) Antagonistas del receptor de fibrinogeno.
ES2153071T3 (es) 2-amino-1,2,3,4-tetrahidronaftalenos y 3-aminocromanos sustituidos en anillo.
JO1704B1 (en) New potent compounds
ES2060709T3 (es) Derivados de piridilo y pirimidilo.
ES2007747A6 (es) Procedimiento de preparacion de 5,6-dihidroxiindol y de su derivado alquilado en posicion 3 y compuestos intermedios.
ES2081314T3 (es) Compuestos de diaminoetileno.
ES2051954T3 (es) 2-aminotiazoles substituidos.
ES8604959A1 (es) Un compuesto
ES2063831T3 (es) Derivados de 4,5,6,7-tetrahidrobencimidazol y su preparacion.
ES2155091T3 (es) Procedimiento para la produccion de inhibidores de la proteasa del vih.
ES2092520T3 (es) Nuevos inhibidores de alfa-manosidasa y fucosidasa.
ES2054186T3 (es) Composicion antihepatopatica.
UA26443A (uk) Похідhі 20,21-диhоребурhамеhіhу, їх рацемати або оптичhі ізомери, або їх адитивhі солі з оргаhічhими кислотами, що мають hоотропhі та аhтидепресивhі властивості
ES2173198T3 (es) Derivados de acido propenoico sustituidos con heterociclos, como antagonistas de nmda.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 375651

Country of ref document: ES